David A. Klibansky

466 total citations
12 papers, 327 citations indexed

About

David A. Klibansky is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David A. Klibansky has authored 12 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David A. Klibansky's work include Pancreatic and Hepatic Oncology Research (5 papers), Gallbladder and Bile Duct Disorders (3 papers) and Pancreatitis Pathology and Treatment (3 papers). David A. Klibansky is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Gallbladder and Bile Duct Disorders (3 papers) and Pancreatitis Pathology and Treatment (3 papers). David A. Klibansky collaborates with scholars based in United States, United Kingdom and Israel. David A. Klibansky's co-authors include Timothy B. Gardner, Stuart R. Gordon, Kaye M. Reid–Lombardo, Daniel Bitran, Richard J. Barth, Imad Nasser, Tracy Challies, Nezam H. Afdhal, Shruti H. Mehta and Gregory J. Tsongalis and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Psychopharmacology.

In The Last Decade

David A. Klibansky

12 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Klibansky United States 7 212 198 105 56 46 12 327
Ya‐Wen Hung Taiwan 7 118 0.6× 34 0.2× 100 1.0× 40 0.7× 153 3.3× 10 314
F. Chapel France 7 30 0.1× 43 0.2× 181 1.7× 29 0.5× 175 3.8× 15 326
Manami Kinjo Japan 11 53 0.3× 148 0.7× 49 0.5× 74 1.3× 2 0.0× 29 327
Alexander Scheiter Germany 7 57 0.3× 39 0.2× 34 0.3× 48 0.9× 12 0.3× 17 194
George Kyriakopoulos Greece 12 23 0.1× 65 0.3× 65 0.6× 22 0.4× 76 1.7× 30 320
Deirdre Doyle Ireland 5 30 0.1× 88 0.4× 28 0.3× 58 1.0× 38 0.8× 12 211
Jun Seok Bae South Korea 8 50 0.2× 177 0.9× 55 0.5× 11 0.2× 3 0.1× 15 469
Joke M. Zuijderwijk Netherlands 11 80 0.4× 51 0.3× 218 2.1× 9 0.2× 4 0.1× 14 364
Jeffrey Y.C. Chao Taiwan 8 256 1.2× 131 0.7× 18 0.2× 63 1.1× 2 0.0× 9 435
Erin Bresnahan United States 8 36 0.2× 58 0.3× 12 0.1× 38 0.7× 30 0.7× 10 187

Countries citing papers authored by David A. Klibansky

Since Specialization
Citations

This map shows the geographic impact of David A. Klibansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Klibansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Klibansky more than expected).

Fields of papers citing papers by David A. Klibansky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Klibansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Klibansky. The network helps show where David A. Klibansky may publish in the future.

Co-authorship network of co-authors of David A. Klibansky

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Klibansky. A scholar is included among the top collaborators of David A. Klibansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Klibansky. David A. Klibansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Duclos, Marie, David A. Klibansky, Heiko Pohl, et al.. (2025). The Effectiveness of Forceps-Assisted Cannulation for Difficult Cannulation During Endoscopic Retrograde Cholangiopancreatography: Results of the SOCCER Randomized Controlled Trial. The American Journal of Gastroenterology. 121(2). 337–344. 1 indexed citations
2.
Kwon, Richard S., Benjamin E. Young, Christopher Lawrence, et al.. (2016). Narcotic Independence After Pancreatic Duct Stenting Predicts Narcotic Independence After Lateral Pancreaticojejunostomy for Chronic Pancreatitis. Pancreas. 45(8). 1126–1130. 6 indexed citations
3.
Walker, John, et al.. (2015). Combined volume reduction with the loop-and-leave technique permits safe endoscopic management of high-risk giant gastric polyps. Gastrointestinal Endoscopy. 83(3). 655–656. 1 indexed citations
4.
Gardner, Timothy B., Kerrington D. Smith, Gregory H. Ripple, et al.. (2014). The Effect of Neoadjuvant Chemoradiation on Pancreatic Cancer-Associated Diabetes Mellitus. Pancreas. 43(7). 1018–1021. 7 indexed citations
5.
Gardner, Timothy B., Lisa Glass, Kerrington D. Smith, et al.. (2013). Pancreatic Cyst Prevalence and the Risk of Mucin-Producing Adenocarcinoma in US Adults. The American Journal of Gastroenterology. 108(10). 1546–1550. 94 indexed citations
6.
Klibansky, David A. & Richard Rothstein. (2012). Robotics in endoscopy. Current Opinion in Gastroenterology. 28(5). 477–482. 15 indexed citations
7.
Young, Benjamin E., Bechien U. Wu, David A. Klibansky, et al.. (2011). Su1426 Do Clinical Outcomes After ERCP With Pancreatic Duct Stenting Predict Clinical Outcomes After Lateral Pancreaticojejunostomy for Patients With Chronic Pancreatitis?. Gastrointestinal Endoscopy. 73(4). AB262–AB262. 1 indexed citations
8.
Klibansky, David A., Kaye M. Reid–Lombardo, Stuart R. Gordon, & Timothy B. Gardner. (2011). The Clinical Relevance of the Increasing Incidence of Intraductal Papillary Mucinous Neoplasm. Clinical Gastroenterology and Hepatology. 10(5). 555–558. 112 indexed citations
9.
Klibansky, David A., Shruti H. Mehta, Michael P. Curry, et al.. (2011). Transient elastography for predicting clinical outcomes in patients with chronic liver disease. Journal of Viral Hepatitis. 19(2). e184–93. 50 indexed citations
10.
Klibansky, David A., et al.. (2011). The Clinical Relevance of Rising IPMN Incidence in the United States. Gastroenterology. 140(5). S–195. 2 indexed citations
11.
Klibansky, David A., Andrew I. Chin, Inga Duignan, & Jay M. Edelberg. (2005). Synergistic targeting with bone marrow-derived cells and PDGF improves diabetic vascular function. American Journal of Physiology-Heart and Circulatory Physiology. 290(4). H1387–H1392. 10 indexed citations
12.
Bitran, Daniel, et al.. (2000). The neurosteroid pregnanolone prevents the anxiogenic-like effect of inescapable shock in the rat. Psychopharmacology. 151(1). 31–37. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ya‐Wen Hung Breakdown of academic impact, for papers by F. Chapel Breakdown of academic impact, for papers by Manami Kinjo Breakdown of academic impact, for papers by Alexander Scheiter Breakdown of academic impact, for papers by George Kyriakopoulos Breakdown of academic impact, for papers by Deirdre Doyle Breakdown of academic impact, for papers by Jun Seok Bae Breakdown of academic impact, for papers by Joke M. Zuijderwijk Breakdown of academic impact, for papers by Jeffrey Y.C. Chao Breakdown of academic impact, for papers by Erin Bresnahan
Rankless by CCL
2026